StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) income statement

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv, Inc. income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin
32.3%
Operating margin
-1.6%
Net margin
2.7%
Return on equity, FY2025
-0.8%

Financial strength

Current ratio
11.30
Debt to equity
–
Debt to assets
–
Cash to current liabilities
152.6%

Valuation

P/E ratio
48.0
Price to sales
1.16
Price to book
1.05
Dividend yield
–

See a number that looks wrong?